Trial Profile
Phase I, Open-Label Study to Evaluate Potential Pharmacokinetic of Orally Administered Oseltamivir in Healthy Obese Thai Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 23 Dec 2013 Results published in the Antimicrobial Agents and Chemotherapy.
- 07 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2010 Planned end date changed from 1 Jun 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.